Home > Press > SMI announces DTRA Phase II SBIR
SMI announces it has received a DTRA Phase II SBIR to address Reprogrammable FPGAs
Posted on August 10, 2006
Structured Materials Industries, Inc. (SMI) reports that it has received a Phase II SBIR from the DTRA to make FPGAs using a proprietary ferroelectric material. Structured Materials Industries, Inc. (SMI) has developed a new ferroelectric that is compatible with silicon interfaces using its own Metal Organic Chemical Vapor Deposition (MOCVD) tool technology. This film has been deposited as a replacement for the traditional silicon dioxide gate dielectric in a silicon metal-oxide-semiconductor process.
SMI's film shows highly promising performance characteristics for FPGA applications compared to commercial/military antifuse technology and/or static random access memory (SRAM) designs.
In the Phase II effort, SMI will optimize the geometry and properties of the ferroelectric (FE) field effect transistor (FET) and integrate the film in a "production quality" commercial fabrication facility. SMI's project team members include qualified part manufacturers.
The technology in this program will be demonstrated at 0.18μm design rules. Importantly, unlike current reprogrammable FPGA approaches, this technology also offers immunity to total dose and single event upsets. This technology is completely compatible with commercial FPGA architectures that utilize antifuse technology and with commercial cluster tool device based manufacturing.
About Structured Materials Industries:
Structured Materials Industries, Incorporated is focused on being the leader in Metal Organic Chemical Vapor Deposition (MOCVD) and related technologies. SMI offers for sale: systems, components, materials, and process development services. SMI has an in-house applications laboratory featuring multi-reactor deposition systems and analytic capabilities, has developed a range of strategic partnerships to develop and implement MOCVD technology and looks forward to continuing to grow and expand upon mutually advantageous relationships.
For more information, please click here.
Contact:Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Chip Technology
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||